Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 111 In -pentetreotide
2. 111-indium-pentetreotide
3. In-111 Pentetreotide
4. Indium In 111 Pentetreotide
5. Indium Ln-111 Pentetreotide
6. Indium-pentetreotide
7. Octreoscan
8. Octreoscan 111
9. Pentetreotide
1. Pentetreotide
2. 138661-02-6
3. Pentetreotide (jan/inn)
4. Schembl1651014
5. Schembl23309836
6. 2-[2-[[2-[[1-[[10-(4-aminobutyl)-16-benzyl-4-(1,3-dihydroxybutan-2-ylcarbamoyl)-7-(1-hydroxyethyl)-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-(carboxymethyl)amino]ethyl-[2-[bis(carboxymethyl)amino]ethyl]amino]acetic Acid
7. Ft-0701094
8. D01859
Molecular Weight | 1394.6 g/mol |
---|---|
Molecular Formula | C63H87N13O19S2 |
XLogP3 | -9.4 |
Hydrogen Bond Donor Count | 17 |
Hydrogen Bond Acceptor Count | 25 |
Rotatable Bond Count | 34 |
Exact Mass | 1393.56825994 g/mol |
Monoisotopic Mass | 1393.56825994 g/mol |
Topological Polar Surface Area | 545 Ų |
Heavy Atom Count | 97 |
Formal Charge | 0 |
Complexity | 2590 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 10 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?